In Reply Dr Gonzalez and colleagues provide detail regarding the New York State Medical Marijuana Program, noting that dispensaries overseen by pharmacists sell regulated products and that certifying practitioners must consult a prescription monitoring program. Some regulation of putatively medical cannabis is clearly better than none, but the New York standards are well below those set for the practice of medicine generally, in which preferred prescribed medications have clinical trial–derived evidence of efficacy and safety in specific doses for specific conditions.
Humphreys K, Saitz R. Cannabis as a Substitute for Opioids—Reply. JAMA. 2019;322(3):273–274. doi:10.1001/jama.2019.6471
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: